If Amedisys Inc. (Nasdaq: AMED) has any concerns as its competitors merge, executives didn't show it during the company's end-of-year earnings call Wednesday. Instead, the Baton Rouge-based company is looking forward to a year with few headwinds, and eyeing new opportunities amid industry consolidation and greater regulatory visibility. The merger between LHC Group (Nasdaq: LHCG) and Almost Read More